Last edition
News about "EBITDA growth "
Indegene Achieves Revenue of INR 6,765 Million in First Quarter FY25
Indegene has announced its financial results, achieving revenue of INR 6,765 million in Q1FY25 with growth of 11.4 percent vs Q1FY24.
EBITDA Growth | 02/08/2024 | By Aishwarya
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members